[Ketamine Augmented Psychotherapy (KAP) in mood disorder: User guide].
L'Encephale June 1, 2022 Hugo Bottemanne, A Baldacci, C Muller et al. 7 citations
Ketamine, a non-competitive NMDA receptor antagonist, is used as a fast-acting antidepressant therapy in depressive disorders. This treatment provokes dissociative effects associating derealization and depersonalization, and a synaptogenic signaling cascade promoting brain plasticity. Despite several preliminary studies suggesting the usefulness of its combination with psychotherapy,...
DOI: 10.1016/j.encep.2021.08.011 (opens in new tab)
Full text (opens in new tab)
Antidepressant
Antidépresseur
Augmented psychotherapy
Belief updating
+9